NRAS and lung cancer: An earlier study reported that magnolol downregulates ERK and Akt phosphorylation, albeit at a higher concentration, in non‐small cell lung cancer cells.19 However, magnolol did not induce any alteration of the pathways in BRAF/NRAS wild‐type melanoma cells and keratinocytes at low concentrations suggestive that magnolol‐induced downregulation of survival pathways might be dependent on the mutation status of cancer cells.